Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07084038Active Not Recruiting

Effect of Glycosuria on Urinary Protein in Patients With Chronic Kidney Disease Treated With SGLT2 Inhibitors

Role: lead

NCT07003828Active Not Recruiting

Hemodialysis-Induced Renal Perfusion Decline: Unraveling the Pathophysiological Mechanisms Linking Intradialytic Circulatory Stress to Residual Renal Function Loss

Role: lead

NCT06587997Not Yet Recruiting

Changes in Renal Perfusion During Hemodialysis in Patients with End-stage Renal Disease

Role: lead

NCT06501222Not ApplicableRecruiting

The Renal Protective Effects of Remote Ischemic Preconditioning in Patients With Chronic Kidney Disease

Role: lead

NCT06275152Not ApplicableEnrolling By Invitation

The Protective Effect of Remote Ischemic Conditioning on Residual Renal Function in Hemodialysis Patients (RIC-HD)

Role: lead

NCT06243900Enrolling By Invitation

NIRS for the Diagnosis of Residual Renal Function Injury in Hemodialysis Patients

Role: lead

All 6 trials loaded